These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20574986)

  • 1. The Alport syndrome COL4A5 variant database.
    Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
    Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene.
    Calderon FR; Phansalkar AR; Crockett DK; Miller M; Mao R
    Hum Mutat; 2007 Oct; 28(10):939-43. PubMed ID: 17486650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of a novel mutation in COL4A5 gene from a Chinese family with X-linked alport syndrome].
    Peng CL; Liang H; Z ou QL; Wang J; Liu CS; Zhang XF; Chen J; Hu SN
    Yi Chuan Xue Bao; 2004 Nov; 31(11):1190-5. PubMed ID: 15651669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
    Tazón-Vega B; Ars E; Burset M; Santín S; Ruíz P; Fernández-Llama P; Ballarín J; Torra R
    Am J Kidney Dis; 2007 Aug; 50(2):257.e1-14. PubMed ID: 17660027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females.
    Wang Y; Zhang H; Ding J; Wang F
    Exp Biol Med (Maywood); 2007 May; 232(5):638-42. PubMed ID: 17463160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome.
    Hertz JM; Juncker I; Marcussen N
    Clin Genet; 2008 Dec; 74(6):522-30. PubMed ID: 18616531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome.
    King K; Flinter FA; Green PM
    Hum Mutat; 2006 Oct; 27(10):1061. PubMed ID: 16941480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
    Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
    Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage analysis and a novel COL4A5 mutation in a large Turkish family with Alport syndrome.
    Tug E; Percin FE; Pala E; Baysoy G
    Genet Couns; 2011; 22(2):143-53. PubMed ID: 21848006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.
    ; Savige J; Ars E; Cotton RG; Crockett D; Dagher H; Deltas C; Ding J; Flinter F; Pont-Kingdon G; Smaoui N; Torra R; Storey H
    Pediatr Nephrol; 2014 Jun; 29(6):971-7. PubMed ID: 23720012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.
    Dagher H; Yan Wang Y; Fassett R; Savige J
    Hum Mutat; 2002 Oct; 20(4):321-2. PubMed ID: 12325029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of COL4A5 gene mutations in Chinese patients with Alport's syndrome.
    Pan X; Yan J; Ren H; Zhang W; Shi H; Yu H; Wang C; Hao C; Chen X; Chen N
    Nephrol Dial Transplant; 2004 May; 19(5):1123-8. PubMed ID: 14993485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mutations in COL4A5 in patients with Alport syndrome.
    Plant KE; Green PM; Vetrie D; Flinter FA
    Hum Mutat; 1999; 13(2):124-32. PubMed ID: 10094548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
    Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
    Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.